<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04265976</url>
  </required_header>
  <id_info>
    <org_study_id>P/2019/448</org_study_id>
    <nct_id>NCT04265976</nct_id>
  </id_info>
  <brief_title>ED Hypernatremia. Prognostic Factors and Epidemiology.</brief_title>
  <acronym>NATSAU</acronym>
  <official_title>Emergency Departement (ED) Hypernatremia. Prognostic Factors and Epidemiology. About a Single-center Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Besancon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Besancon</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluate the 1-month mortality of patients who proceed a blood sample while in the
      ED with an hypernatremia (&gt;145 mmol/l). This prospective study will try to show several
      prognostic factors, and show the epidemiology of hypernatremia in this single center
      evaluation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 26, 2019</start_date>
  <completion_date type="Anticipated">September 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">May 26, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>one month survival</measure>
    <time_frame>1 month</time_frame>
    <description>Survival at 1 month after the blood sample at the ED</description>
  </primary_outcome>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Hypernatremia</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Every &gt;18 years old patient from who a blood sample was taken in the ED with a natremia &gt;
        145 mmol/l and don't show a refusal after information.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Natremia &gt; 145 mmol/l

        Exclusion Criteria:

          -  Age &lt; 18 years

          -  Refusal
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Romain ADAM, Resident</last_name>
    <phone>+33646470168</phone>
    <email>radam@chu-besancon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Besançon</name>
      <address>
        <city>Besançon</city>
        <zip>25000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Romain ADAM, Resident</last_name>
      <phone>+33646470168</phone>
      <email>radam@chu-besancon.fr</email>
    </contact>
    <contact_backup>
      <last_name>Noémie NMINEJ</last_name>
      <email>nnminej@chu-besancon.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 10, 2020</study_first_submitted>
  <study_first_submitted_qc>February 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 12, 2020</study_first_posted>
  <last_update_submitted>February 13, 2020</last_update_submitted>
  <last_update_submitted_qc>February 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypernatremia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

